Literature DB >> 11133239

Biochemical studies of myosin.

K M Trybus1.   

Abstract

This article describes methods for expressing and obtaining purified smooth muscle myosin subfragments using the baculovirus/insect cell expression system, as well as methods for purifying whole myosin from tissue. Protocols for several gel assays that are routinely used with myosin are given, including gels to monitor light chain phosphorylation state and native gels to determine protein homogeneity. Steady-state myosin ATPase and actin-activated ATPase determinations are described, as are some of the more basic transient-state kinetic parameters that can be measured. The in vitro motility assay, in which the rate of actin movement over myosin or its subfragments is quantified, is also presented. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11133239     DOI: 10.1006/meth.2000.1085

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  36 in total

1.  Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle.

Authors:  Anja M Swenson; Wanjian Tang; Cheavar A Blair; Christopher M Fetrow; William C Unrath; Michael J Previs; Kenneth S Campbell; Christopher M Yengo
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  Phosphorylation of a single head of smooth muscle myosin activates the whole molecule.

Authors:  Arthur S Rovner; Patricia M Fagnant; Kathleen M Trybus
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

3.  Mutation of a conserved glycine in the SH1-SH2 helix affects the load-dependent kinetics of myosin.

Authors:  Neil M Kad; Joseph B Patlak; Patricia M Fagnant; Kathleen M Trybus; David M Warshaw
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

4.  Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function.

Authors:  Ruth F Sommese; Jongmin Sung; Suman Nag; Shirley Sutton; John C Deacon; Elizabeth Choe; Leslie A Leinwand; Kathleen Ruppel; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

5.  Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin.

Authors:  Hailong Lu; Patricia M Fagnant; Carol S Bookwalter; Peteranne Joel; Kathleen M Trybus
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-07       Impact factor: 11.205

6.  Fission yeast myosin Myo2 is down-regulated in actin affinity by light chain phosphorylation.

Authors:  Luther W Pollard; Carol S Bookwalter; Qing Tang; Elena B Krementsova; Kathleen M Trybus; Susan Lowey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

7.  A Toxoplasma gondii class XIV myosin, expressed in Sf9 cells with a parasite co-chaperone, requires two light chains for fast motility.

Authors:  Carol S Bookwalter; Anne Kelsen; Jacqueline M Leung; Gary E Ward; Kathleen M Trybus
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

8.  The Qdot-labeled actin super-resolution motility assay measures low-duty cycle muscle myosin step size.

Authors:  Yihua Wang; Katalin Ajtai; Thomas P Burghardt
Journal:  Biochemistry       Date:  2013-02-21       Impact factor: 3.162

9.  Functional diversity among a family of human skeletal muscle myosin motors.

Authors:  Daniel I Resnicow; John C Deacon; Hans M Warrick; James A Spudich; Leslie A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

10.  A point mutation in the regulatory light chain reduces the step size of skeletal muscle myosin.

Authors:  Jennifer J Sherwood; Guillermina S Waller; David M Warshaw; Susan Lowey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.